GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
Clinical trial NCT06235242 · TERMINATED
Trial details
- NCT number
- NCT06235242
- Sponsor
- Grit Biotechnology
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-02
- Primary completion
- 2025-12-30
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.